IKKβ/NF-κB and the miscreant macrophage
Authors:
Open Access
- 2 June 2008
- journal article
- editorial
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 205 (6) , 1255-1259
Abstract
Macrophage activation relies on complex intracellular signaling processes that integrate the need for rapid inflammatory responses to pathogens with the need to resolve inflammation without permanent harm to normal tissues. Patterns of aberrant macrophage activation characterize and sustain disorders of chronic inflammation, infection, and cancer. New studies now show a role for the NF-κB activator IKKβ in promoting an alternative, immunosuppressive pattern of macrophage activation, which limits the cell's tumoricidal and bactericidal capacities. As cancers and pathogens may have evolved multiple mechanisms to manipulate macrophages for their own survival, is there anything we can do about it?Keywords
This publication has 35 references indexed in Scilit:
- Evaluation of HIF-1 inhibitors as anticancer agentsDrug Discovery Today, 2007
- HIF-1α expression regulates the bactericidal capacity of phagocytesJournal of Clinical Investigation, 2005
- A chemokine receptor antagonist inhibits experimental breast tumor growth.2003
- HIF-1α Is Essential for Myeloid Cell-Mediated InflammationCell, 2003
- The many faces of macrophage activationJournal of Leukocyte Biology, 2003
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- NF-κB regulation in the immune systemNature Reviews Immunology, 2002
- Possible new role for NF-κB in the resolution of inflammationNature Medicine, 2001
- Cutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide ProductionThe Journal of Immunology, 2001
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000